The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.
VIENNA, AUSTRIA — Thrombi were sometimes found on two left-atrial-appendage (LAA) occluder devices in the weeks following implantation in two large registry studies of patients with atrial ...
Please provide your email address to receive an email when new articles are posted on . AF recurrence after catheter ablation was not linked to adverse outcomes, but a nonsignificant trend for worse ...
Columbus Regional Health Heart & Vascular announced that its cardiovascular services team recently completed its 100th Watchman™ procedure, which treats patients with atrial fibrillation (AFib).
Medical Device Network on MSN
Gore acquires Conformal Medical to broaden endovascular portfolio
Under the acquisition, Gore will inherit Conformal’s CLAAS AcuForm system for left atrial appendage closure to mitigate stroke risk.
The U.S. FDA expanded the approval for use of Boston Scientific Corp.’s Watchman Flx and Watchman Flx Pro left atrial appendage closure (LAAC) devices to include post-ablation patients, bringing good ...
SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback